Masanori Sasaki Selected Research

Myristoylated Alanine-Rich C Kinase Substrate

5/2014

Alteration in MARCKS phosphorylation and expression by methylmercury in SH-SY5Y cells and rat brain.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Masanori Sasaki Research Topics

Disease

14	Stroke (Strokes) 07/2022 - 01/2009
13	Spinal Cord Injuries (Spinal Cord Injury) 07/2022 - 09/2004
5	Brain Ischemia (Cerebral Ischemia) 12/2021 - 01/2009
5	Cerebral Infarction 02/2019 - 02/2013
4	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 02/2019 - 01/2009
4	Demyelinating Diseases (Demyelinating Disease) 01/2018 - 02/2006
3	Ischemic Stroke 07/2022 - 10/2017
2	Hemorrhage 11/2021 - 03/2017
2	Disease Progression 01/2021 - 01/2021
2	Neoplasms (Cancer) 01/2019 - 02/2004
2	Glioma (Gliomas) 06/2018 - 02/2017
2	Infections 06/2017 - 01/2017
1	Chronic Brain Injury 07/2022
1	Atrial Fibrillation 07/2022
1	Embolic Stroke 07/2022
1	Edema (Dropsy) 11/2021
1	Interstitial Cystitis (Interstitial Cystitis, Chronic) 11/2021
1	Bone Resorption 05/2021
1	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 01/2021
1	Hypertension (High Blood Pressure) 12/2020
1	Pathologic Constriction (Stenosis) 10/2019
1	Hyperplasia 10/2019
1	Cytokine Release Syndrome 01/2019
1	Cerebral Small Vessel Diseases 01/2019
1	Brain Hypoxia-Ischemia (Hypoxia Ischemia, Brain) 11/2018
1	Cerebral Palsy (Spastic Diplegia) 11/2018
1	Brain Stem Infarctions (Weber Syndrome) 10/2018
1	Glioblastoma (Glioblastoma Multiforme) 06/2018
1	Astrocytoma (Pilocytic Astrocytoma) 06/2018
1	Erectile Dysfunction 03/2018
1	Status Epilepticus (Complex Partial Status Epilepticus) 01/2018
1	Epilepsy (Aura) 01/2018
1	Intracranial Hemorrhages (Intracranial Hemorrhage) 10/2017
1	Arteriovenous Malformations (Arteriovenous Malformation) 07/2017
1	Sinusitis 06/2017
1	Central Nervous System Cavernous Hemangioma 03/2017
1	Intracranial Aneurysm (Cerebral Aneurysm) 01/2017
1	Osteonecrosis (Kienbock's Disease) 01/2017
1	Wounds and Injuries (Trauma) 01/2017
1	Coinfection 01/2017
1	Aneurysm (Aneurysms) 01/2017
1	Parkinson Disease (Parkinson's Disease) 01/2015
1	Neuroblastoma 05/2014
1	Multiple Sclerosis 10/2010
1	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 10/2010
1	Knee Osteoarthritis 05/2004
1	Squamous Cell Carcinoma of Head and Neck 02/2004
1	Inflammation (Inflammations) 05/2003
1	Foreign Bodies (Foreign Body) 05/2003

Drug/Important Bio-Agent (IBA)

6	Therapeutic UsesIBA 01/2021 - 05/2012
3	Brain-Derived Neurotrophic Factor (BDNF)IBA 02/2019 - 03/2006
3	Messenger RNA (mRNA)IBA 06/2018 - 02/2017
2	Biological ProductsIBA 05/2021 - 07/2017
2	Nerve Growth Factors (Neurotrophins)IBA 01/2021 - 01/2018
2	ParaffinIBA 06/2018 - 02/2017
2	Formaldehyde (Formol)FDA Link 06/2018 - 02/2017
2	Interleukin-6 (Interleukin 6)IBA 07/2017 - 03/2017
2	Thromboplastin (Tissue Factor)IBA 07/2017 - 03/2017
2	Green Fluorescent ProteinsIBA 02/2006 - 09/2004
2	hylanIBA 05/2004 - 05/2003
2	Hyaluronic Acid (Hyaluronan)IBA 05/2004 - 05/2003
1	apixabanIBA 07/2022
1	RivaroxabanIBA 07/2022
1	AnticoagulantsIBA 07/2022
1	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 07/2022
1	Thrombin FDA Link 07/2022
1	Factor Xa (Coagulation Factor Xa)IBA 07/2022
1	Dabigatran FDA Link 07/2022
1	Hematoxylin (Haematoxylon)IBA 11/2021
1	Eosine Yellowish-(YS) (Eosin)IBA 11/2021
1	NeurturinIBA 01/2021
1	Neoplasm AntibodiesIBA 01/2019
1	bispecific antibody ERY974IBA 01/2019
1	Interleukin-13 Receptors (Interleukin 13 Receptor)IBA 06/2018
1	Tissue Plasminogen Activator (Alteplase)FDA Link 10/2017
1	Denosumab FDA Link 01/2017
1	Myristoylated Alanine-Rich C Kinase SubstrateIBA 05/2014
1	Neuroprotective AgentsIBA 05/2012
1	CytokinesIBA 05/2011
1	Myelin-Oligodendrocyte GlycoproteinIBA 10/2010
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 10/2010
1	Peptides (Polypeptides)IBA 02/2004
1	AntigensIBA 02/2004
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 02/2004
1	HLA-A24 AntigenIBA 02/2004

Therapy/Procedure

20	Intravenous Infusions 07/2022 - 02/2013
12	Therapeutics 07/2022 - 01/2008
8	Transplantation 02/2013 - 03/2006
2	Intravenous Administration 11/2021 - 11/2018
2	Stents 10/2019 - 01/2017
2	Immunotherapy 01/2019 - 02/2004
1	Secondary Prevention 07/2022
1	Prostheses and Implants (Prosthesis) 05/2021
1	Cell- and Tissue-Based Therapy (Cell Therapy) 01/2018
1	Dentures 06/2017
1	Operative Surgical Procedures 01/2017
1	Tooth Extraction (Tooth Extractions) 01/2017
1	Spinal Injections 10/2010
1	Craniotomy 01/2009